Paper37568635
Recent Advances in Clinical Research for Skin Cancer Chemoprevention.
Tow R and 7 others. Cancers (Basel), 2023. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Recent Advances in Clinical Research for Skin Cancer Chemoprevention. Papers, record 37568635. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37568635
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA269653 | NCI NIH HHS | United States | R01CA269653 | PubMed and NIH |
Source NIH RePORTER
References67
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26714773 | When "Effective" Prevention Agents Fail to Elicit Anticipated Effects: Challenges in Trial Design. | Cancer Prev Res (Phila) | 2016 | https://conductscience.org/library/papers/26714773 | PubMed |
| 2 | 35794547 | Associations of thiazide use with skin cancers: a systematic review and meta-analysis. | BMC Med | 2022 | https://conductscience.org/library/papers/35794547 | PubMed |
| 3 | 31912902 | Cancer statistics, 2020. | CA Cancer J Clin | 2020 | https://conductscience.org/library/papers/31912902 | PubMed |
| 4 | 29691233 | Evaluation of Biodistribution of Sulforaphane after Administration of Oral Broccoli Sprout Extract in Melanoma Patients with Multiple Atypical Nevi. | Cancer Prev Res (Phila) | 2018 | https://conductscience.org/library/papers/29691233 | PubMed |
| 5 | 35620919 | Ototoxicity of Long-Term α-Difluoromethylornithine for Skin Cancer Prevention. | Laryngoscope | 2023 | https://conductscience.org/library/papers/35620919 | PubMed |
| 6 | 20698351 | Chemopreventive efficacy of topical difluoromethylornithine and/or triamcinolone in the treatment of actinic keratoses analyzed by karyometry. | Anal Quant Cytol Histol | 2009 | https://conductscience.org/library/papers/20698351 | PubMed |
| 7 | 36293471 | The Use of Retinoids for the Prevention and Treatment of Skin Cancers: An Updated Review. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36293471 | PubMed |
| 8 | 29103328 | Skin cancer associated with commonly prescribed drugs: tumor necrosis factor alpha inhibitors (TNF-αIs), angiotensin-receptor blockers (ARBs), phosphodiesterase type 5 inhibitors (PDE5Is) and statins -weighing the evidence. | Expert Opin Drug Saf | 2018 | https://conductscience.org/library/papers/29103328 | PubMed |
| 9 | 33318091 | The efficacy and safety of sunscreen use for the prevention of skin cancer. | CMAJ | 2020 | https://conductscience.org/library/papers/33318091 | PubMed |
| 10 | 37403007 | The Evolving Treatment Landscape of Merkel Cell Carcinoma. | Curr Treat Options Oncol | 2023 | https://conductscience.org/library/papers/37403007 | PubMed |
| 11 | 25444899 | Skin cancer and new treatment perspectives: a review. | Cancer Lett | 2015 | https://conductscience.org/library/papers/25444899 | PubMed |
| 12 | 20103724 | A phase 2a study of topical perillyl alcohol cream for chemoprevention of skin cancer. | Cancer Prev Res (Phila) | 2010 | https://conductscience.org/library/papers/20103724 | PubMed |
| 13 | 23364005 | Randomized controlled trial of oral omega-3 PUFA in solar-simulated radiation-induced suppression of human cutaneous immune responses. | Am J Clin Nutr | 2013 | https://conductscience.org/library/papers/23364005 | PubMed |
| 14 | 24917395 | Aldo-keto reductase 1C3 is overexpressed in skin squamous cell carcinoma (SCC) and affects SCC growth via prostaglandin metabolism. | Exp Dermatol | 2014 | https://conductscience.org/library/papers/24917395 | PubMed |
| 15 | 26488693 | A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention. | N Engl J Med | 2015 | https://conductscience.org/library/papers/26488693 | PubMed |
| 16 | 34638427 | Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N-Methyltransferase as a Biomarker in Skin Cancers. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34638427 | PubMed |
| 17 | 27061568 | A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients. | Br J Dermatol | 2016 | https://conductscience.org/library/papers/27061568 | PubMed |
| 18 | 25658450 | Nicotinamide enhances repair of arsenic and ultraviolet radiation-induced DNA damage in HaCaT keratinocytes and ex vivo human skin. | PLoS One | 2015 | https://conductscience.org/library/papers/25658450 | PubMed |
| 19 | 36856623 | Skin-Cancer Chemoprevention in Transplant Recipients. | N Engl J Med | 2023 | https://conductscience.org/library/papers/36856623 | PubMed |
| 20 | 33482124 | Cancer Moonshot 2.0. | Lancet Oncol | 2021 | https://conductscience.org/library/papers/33482124 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41890982 | Targeting β2-adrenergic receptor reduces UV-induced cutaneous damage and inflammation in a murine model. | J Photochem Photobiol | 2025 | https://conductscience.org/library/papers/41890982 | PubMed |
| 41598211 | Multiple Basal Cell Carcinomas in a Long-Term Survivor of Childhood ALL and HSCT-A Call for Dermatologic Vigilance. | Life (Basel) | 2025 | https://conductscience.org/library/papers/41598211 | PubMed |
| 41177430 | Tetrahedral framework nucleic acids: Nanokeys unlocking a new era of precision biomedicine. | J Adv Res | 2026 | https://conductscience.org/library/papers/41177430 | PubMed |
| 40710294 | Targeting Skin Neoplasms: A Review of Berberine's Anticancer Properties. | Cells | 2025 | https://conductscience.org/library/papers/40710294 | PubMed |
| 40376946 | Updates in clinical trial-explored chemopreventive agents for cutaneous melanoma: mechanisms affecting melanocytes. | Melanoma Manag | 2025 | https://conductscience.org/library/papers/40376946 | PubMed |
| 40352638 | Emerging Technologies for Timely Point-of-Care Diagnostics of Skin Cancer. | Glob Chall | 2025 | https://conductscience.org/library/papers/40352638 | PubMed |
| 40325810 | Optimization, Preparation, and Cytotoxic Potential of Pyrus communis Extract Loaded Ethosomes on Skin Cancer Cell Lines. | Curr Top Med Chem | 2026 | https://conductscience.org/library/papers/40325810 | PubMed |
| 40191461 | Oral delivery of the non-β-blocking R-carvedilol enantiomer for skin cancer chemoprevention in SKH-1 mice. | AAPS Open | 2025 | https://conductscience.org/library/papers/40191461 | PubMed |
| 39041265 | Nanoemulsions in Skin Cancer Therapy: A Promising Frontier. | Curr Pharm Biotechnol | 2025 | https://conductscience.org/library/papers/39041265 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MT-CO1 | 4512 | PubTator's text mining | https://conductscience.org/library/genes/4512 | NCBI Gene |
| NNMT | 4837 | PubTator's text mining | https://conductscience.org/library/genes/4837 | NCBI Gene |
| ODC1 | 4953 | PubTator's text mining | https://conductscience.org/library/genes/4953 | NCBI Gene |
| PTCH1 | 5727 | PubTator's text mining | https://conductscience.org/library/genes/5727 | NCBI Gene |
| PTGS2 | 5743 | PubTator's text mining | https://conductscience.org/library/genes/5743 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37568635
GET https://conductscience.org/api/papers/v1/37568635/references?page=2